Page last updated: 2024-08-21

thiazoles and Abdominal Obesity

thiazoles has been researched along with Abdominal Obesity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanley, AJ; Harris, SB; Retnakaran, R; Ye, C; Zinman, B	1
Barrett, PH; Chan, DC; Ooi, EM; Sprecher, DL; Watts, GF	1

Trials

2 trial(s) available for thiazoles and Abdominal Obesity

Article	Year
Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:1 Topics: Alanine Transaminase; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Liver; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Obesity, Abdominal; Thiazoles; Waist-Hip Ratio	2012
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:10 Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Cholesterol; Cross-Over Studies; Double-Blind Method; Dyslipidemias; Humans; Kinetics; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Obesity, Abdominal; PPAR delta; Thiazoles; Triglycerides	2011

Article

Year

Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.

Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:1

Topics: Alanine Transaminase; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Liver; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Obesity, Abdominal; Thiazoles; Waist-Hip Ratio

2012

Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.

The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:10

Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Cholesterol; Cross-Over Studies; Double-Blind Method; Dyslipidemias; Humans; Kinetics; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Obesity, Abdominal; PPAR delta; Thiazoles; Triglycerides

2011